haloperidol has been researched along with Acquired Metabolic Diseases, Brain in 2 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morice, E | 1 |
| Billard, JM | 1 |
| Denis, C | 1 |
| Mathieu, F | 1 |
| Betancur, C | 1 |
| Epelbaum, J | 1 |
| Giros, B | 1 |
| Nosten-Bertrand, M | 1 |
| Halim, ND | 1 |
| Lipska, BK | 1 |
| Hyde, TM | 1 |
| Deep-Soboslay, A | 1 |
| Saylor, EM | 1 |
| Herman, MM | 1 |
| Thakar, J | 1 |
| Verma, A | 1 |
| Kleinman, JE | 1 |
2 other studies available for haloperidol and Acquired Metabolic Diseases, Brain
| Article | Year |
|---|---|
Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia.
Topics: Animals; Brain Diseases, Metabolic; Cognition Disorders; Disease Models, Animal; Dopamine; Dopamine | 2007 |
Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds.
Topics: Animals; Antipsychotic Agents; Artifacts; Brain; Brain Chemistry; Brain Diseases, Metabolic; Cerebel | 2008 |